Real-world Resource Use and Costs of CAR-T Therapies in Diffuse Large B-cell Lymphoma (DLBCL): Inpatient and Outpatient Settings
Clinical trial NCT05918809 · COMPLETED
Trial details
- NCT number
- NCT05918809
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-07-25
- Primary completion
- 2022-06-17
- Enrollment
- 1031
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.